Africa (WHO region) vs Slovakia: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Slovakia
100.0%
in 2021
Africa (WHO region) rank
2nd
Slovakia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Slovakia
How they compare
Slovakia currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 7 shared years of data; in 2005 it was Slovakia ahead.
Africa (WHO region) ranks 2nd and Slovakia ranks 1st of 11 groups.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.5% | 100.0% | 67.5% | Slovakia |
| 2010s | 75.3% | 91.7% | 16.3% | Slovakia |
| 2020s | 91.5% | 100.0% | 8.5% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Slovakia?
- Slovakia, at 100.0% against 96.0% in Africa (WHO region) as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Slovakia?
- 4.0%, with Slovakia ahead.
- How many years of comparable data are there for Africa (WHO region) and Slovakia?
- 7 years are reported by both, from 2005 to 2021.
- How do Africa (WHO region) and Slovakia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Slovakia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.